1. Home
  2. JRVR vs HRTX Comparison

JRVR vs HRTX Comparison

Compare JRVR & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James River Group Holdings Ltd.

JRVR

James River Group Holdings Ltd.

N/A

Current Price

$6.39

Market Cap

265.7M

Sector

Finance

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.97

Market Cap

265.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JRVR
HRTX
Founded
2002
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.7M
265.9M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
JRVR
HRTX
Price
$6.39
$0.97
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$6.75
$4.50
AVG Volume (30 Days)
235.3K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.63%
N/A
EPS Growth
125.82
N/A
EPS
0.79
N/A
Revenue
$687,614,000.00
$154,904,000.00
Revenue This Year
$1.50
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
$8.07
N/A
Revenue Growth
N/A
7.36
52 Week Low
$3.85
$0.93
52 Week High
$7.20
$2.61

Technical Indicators

Market Signals
Indicator
JRVR
HRTX
Relative Strength Index (RSI) 42.34 31.47
Support Level $6.28 N/A
Resistance Level $7.02 $1.36
Average True Range (ATR) 0.29 0.09
MACD -0.07 -0.02
Stochastic Oscillator 21.64 10.00

Price Performance

Historical Comparison
JRVR
HRTX

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: